Bausch Health/BHC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Bausch Health

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Ticker

BHC

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Thomas Appio

Employees

20,270

Headquarters

Laval, Canada

Bausch Health Metrics

BasicAdvanced
$2.4B
Market cap
-
P/E ratio
-$1.24
EPS
0.95
Beta
-
Dividend rate
$2.4B
0.95352
$11.32
$6.11
394K
1.225
0.854
51.148
1.19%
-1.83%
-2.27%
0.264
3.021
7.35%
-19.48%
2.94%

What the Analysts think about Bausch Health

Analyst Ratings

Majority rating from 4 analysts.
Hold

Bausch Health Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-2.97% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.2B
-10.59%
Net income
-$64M
64.10%
Profit margin
-2.97%
84.47%

Bausch Health Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 16.39%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.82
$1.02
$1.15
$0.60
-
Expected
$0.76
$0.90
$1.00
$0.72
$0.88
Surprise
7.61%
13.92%
14.50%
-16.39%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bausch Health stock?

Bausch Health (BHC) has a market cap of $2.4B as of June 14, 2024.

What is the P/E ratio for Bausch Health stock?

The price to earnings (P/E) ratio for Bausch Health (BHC) stock is 0 as of June 14, 2024.

Does Bausch Health stock pay dividends?

No, Bausch Health (BHC) stock does not pay dividends to its shareholders as of June 14, 2024.

When is the next Bausch Health dividend payment date?

Bausch Health (BHC) stock does not pay dividends to its shareholders.

What is the beta indicator for Bausch Health?

Bausch Health (BHC) has a beta rating of 0.95. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Bausch Health stock price target?

The target price for Bausch Health (BHC) stock is $9.75, which is NaN% below the current price of $. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Bausch Health stock

Buy or sell Bausch Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing